The clinical use of androgens in female sexual disorders

Journal of Sex and Marital Therapy

Volumn 24, Issue 3, 1998, Pages 153-163

  Davis, Susan R ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; METHYLTESTOSTERONE; PRASTERONE; TESTOSTERONE UNDECANOATE;

ACNE; ADULT; ANDROGEN THERAPY; DRUG FORMULATION; DRUG SAFETY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LUTEINIZING HORMONE RELEASE; REVIEW; TESTOSTERONE BLOOD LEVEL; TREATMENT INDICATION; VIRILIZATION;

EID: 0031859518     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926239808404930     Document Type: Article

References (41)

1. Frock J, Money J. Sexuality and the menopause. PsychotherPsychosom 57:29-33, 1992.
2. Steinberg KK, Freni-titulaer LW, De Puey EG. Sex steroids and bone density in premenopausal and permenopausal women. J. Clin Endocrinol Metab 69: 533-539, 1989.
3. Hallstrom T. Sexuality in the climacteric. Clin Obstet Gynecol 4: 227-239, 1977
4. Sands, R, Studd J. Exogenous androgens in postmenopausal women. Am J Med 98: 765-795, 1995.
5. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 80:1429-1430, 1995.
6. Zumoff B, Rosenfeld RS, Strain GW. Sex differences in die 24 hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 51: 330-334, 1980.
7. Judd HL, Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 19: 775-788, 1976.
8. Vaitukaitis JL, Dale SL, MelbyJC. Role of ACTH in the secretion of free DHA and its sulphate ester in man. J Clin Endocrinol Metab 29:1443-1447, 1969.
9. Vermeulen A, Ando S. Prolactin and adrenal androgen secretion. Clin Endocrinol (Oxf) 8: 295-303, 1978.
10. Haning RV Jr, Cabot M, Flood CA, Hackett R, Longcope C. Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS) its metabolism to dehydroepiandrosterone, androstenedione testosterone and dihydrotestosterone, and die effects of increased plasm DS concentration on DS MCR in normal women. J Clin Endocrinol Metab 69:1047-1052, 1989.
11. Rannevik G, Jeppsson S, Johnell O.A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 8:189-196, 1986.
12. Dunn JF, Nisula BC, Rodboard D. Transport of steroid hormones. Binding of 21 endogenous steroids to both testosterone-binding globulin and cortico-steroid-binding globulin in human plasma. J Clin Endocrinol Metab 53: 58-68, 1981.
13. Judd HL, Yen SSC. Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab 36: 475-481, 1973.
14. Mushayandebvu T, Castracane DV, Gimpel T, Adel T, Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril 65: 721-723, 1996.
15. Meldrum D. Changes in circulating steroids with aging in post menopausal women. Obstet Gynecol 57: 624-628, 1997.
16. Longcope, C, Franz C, Morello, C, Baker K, Johnson CC, Jr. Steroid and gonadotropin levels in women during die peri-menopausal years. Maturitas 8:189-196, 1986.
17. Judd HL, Lucas WE, Yen SSC. Effect of oopherectomy on circulating testosterone and androstenedione levels in patients widi endometrial cancer. Am J Obstet Gynecol 118(6): 793-8, 1974.
18. Tazuke S, Khaw K-T, Chir MBB, Barrett-Connor E. Exogenous estrogen and endogenous sex hormones. Medicine 71: 44-51, 1992.
19. Mathur RS, Landgreve SC, Moody LO, Semmens JP, Williamson HO. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas 7:129-133, 1985.
20. Krug R, Psych D, Pietrowsky R, Fehm HL, Born J. Selective influence of menstrual cycle on perception of stimuli widi reproductive significance. Psychosom Med 56: 410-417, 1994.
21. Bancroft J, Cawood EHH. Androgens and die menopause: A study of 40-60 year-old women. Clin Endocrinol 45: 577-587, 1996.
22. Abraham GE, Ovarian and adrenal contribution to peripheral androgens during die menstrual cycle. J Clin Endocrinol Metab 39: 340-346, 1974.
23. McCoy, NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 7: 203-210, 1985.
24. Dennerstein L, Smith A, Morse, Burger H. Sexuality and the menopause. J Psychosom Obstet Gynecol 15: 56-59, 1994.
25. Utian WH. The true clinical features of postmenopausal oophorectomy and their response to estrogen replacement therapy. S Afr Med J 46: 732-737, 1972.
26. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 4: 31-47, 1977.
27. Studd JWW, Colins WP, Chakravarti S. Estradiol and testosterone implants in the treatment of psychosexual problems in postmenopausal women. Br J Obstet Gynaecol 84: 314-315, 1977.
28. Sherwin BN, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: A prespective, crossover study of sex steroid administration in surgical menopause. Psychosom Med 47: 339-351, 1997.
29. Bachmann GA, Leiblum SR. Sexuality in sexagenarian women. Maturitas 13: 45-50, 1991.
30. Bixo M, Backstrom T, Winblad B, Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 55: 297-303, 1995.
31. Roselli CE, Resko JA. Aromatase activity in the rat brain: Hormone regulation and sex differences. J Steroid Biochem Mol Biol 44: 499-508, 1993.
32. Van Goozen SHM, Cohen-Kettensis PT, Gooren LIG, Frijda NH, Van de Poll NE. Gender differences in behaviour: Activating effects of cross-sex hormones. Psycho-neuroendocrinology 20: 343-363, 1995.
33. Studd JWW, Chakravarti S, Oram D. The climacteric. Clin Obstet Gynecol 4: 3-29, 1977.
34. Burger HG, Hailes J, Menelaus M. The management of persistent symptoms with estradiol-testosterone implants: Clinical, lipid and hormonal results. Maturitas 6: 351-358, 1984.
35. Burger HG, Hailes J, Nelson J, Menelaus M. Effect of combined implants of estradiol and testosterone on lTetrahedron Letto in postmenopausal women. Br Med J 294:936-937, 1987.
36. Davis SR, McCloud PI, Strauss BJG, Burger HG. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas 21:227-236, 1995.
37. Dow MGT, Hart DM, Forrest CA. Hormonal treatments of sexual unresponsiveness in postmenopausal women: A comparative study. Br J Obstet Gynaecol 90: 361-366, 1983.
38. Barrett-Connor E, Timmons MC, Young R, Wiita B, Estratest Working Group. Interim safety analysis of a two-year study comparing oral estrogen-androgen and congugated estrongens in surgically menopausal women.J Women’s Health 5: 593-602, 1996.
39. Raisz LG, Wiita B, Artis A, et al. Comparison of die effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women.J Clin Endocrinol Metab 81: 37-43, 1995.
40. Watts NB, Notelovitz M, Timmons MC. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 85: 529-537, 1995.
41. Secreto G, Toniolo P, Berrino E, et al. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 51: 2572-2576, 1991.